Temperature-controlled containers for pharmaceutical transport.
| Date | Round | Amount |
|---|---|---|
| Jun 2024 | Series D Plus Swiss deeptech SkyCell closed a $116M Series D from Tybourne Capital, CCI and M&G Investments' Catalyst for its pharma cold-chain containers. | $116M |
| Oct 2023 | Funding round Swiss pharma-logistics startup SkyCell raised $57M from M&G Investments Catalyst to scale its hybrid containers. | $57M |